[HTML][HTML] Stem cell-based therapy for human diseases
DM Hoang, PT Pham, TQ Bach, ATL Ngo… - Signal transduction and …, 2022 - nature.com
Recent advancements in stem cell technology open a new door for patients suffering from
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
S Chidambaranathan-Reghupaty, PB Fisher… - Advances in cancer …, 2021 - Elsevier
Hepatocellular carcinoma (HCC), the primary malignancy of hepatocytes, is a diagnosis with
bleak outcome. According to National Cancer Institute's SEER database, the average five …
bleak outcome. According to National Cancer Institute's SEER database, the average five …
[HTML][HTML] Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Z Luo, M Tian, G Yang, Q Tan, Y Chen, G Li… - Signal transduction and …, 2022 - nature.com
Molecular oxygen (O2) is essential for most biological reactions in mammalian cells. When
the intracellular oxygen content decreases, it is called hypoxia. The process of hypoxia is …
the intracellular oxygen content decreases, it is called hypoxia. The process of hypoxia is …
[HTML][HTML] Intestinal barrier and permeability in health, obesity and NAFLD
The largest surface of the human body exposed to the external environment is the gut. At this
level, the intestinal barrier includes luminal microbes, the mucin layer, gastrointestinal …
level, the intestinal barrier includes luminal microbes, the mucin layer, gastrointestinal …
[HTML][HTML] Beneficial effects of betaine: a comprehensive review
MK Arumugam, MC Paal, TM Donohue Jr, M Ganesan… - Biology, 2021 - mdpi.com
Simple Summary A large number of studies report that medicinal herbs and many food
ingredients protect against the development of liver disease because they possess …
ingredients protect against the development of liver disease because they possess …
[HTML][HTML] Antioxidant peptides from monkfish swim bladders: Ameliorating NAFLD in vitro by suppressing lipid accumulation and oxidative stress via regulating AMPK …
MF Wu, QH Xi, Y Sheng, YM Wang, WY Wang, CF Chi… - Marine drugs, 2023 - mdpi.com
In this study, we investigate the ameliorating functions of QDYD (MSP2), ARW (MSP8),
DDGGK (MSP10), YPAGP (MSP13) and DPAGP (MSP18) from monkfish swim bladders on …
DDGGK (MSP10), YPAGP (MSP13) and DPAGP (MSP18) from monkfish swim bladders on …
[HTML][HTML] Positive effects of exercise intervention without weight loss and dietary changes in NAFLD-related clinical parameters: a systematic review and meta-analysis
AF Babu, S Csader, J Lok, C Gómez-Gallego… - Nutrients, 2021 - mdpi.com
One of the focuses of non-alcoholic fatty liver disease (NAFLD) treatment is exercise.
Randomized controlled trials investigating the effects of exercise without dietary changes on …
Randomized controlled trials investigating the effects of exercise without dietary changes on …
MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy
YX Xian, JP Weng, F Xu - Chinese medical journal, 2021 - mednexus.org
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, placing an increasing burden on human health. NAFLD is a complex …
worldwide, placing an increasing burden on human health. NAFLD is a complex …
[HTML][HTML] Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B
Background & Aims A recent consensus document has defined metabolic dysfunction-
associated fatty liver disease (MAFLD) as hepatic steatosis together with overweight …
associated fatty liver disease (MAFLD) as hepatic steatosis together with overweight …
[HTML][HTML] Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
P Zarghamravanbakhsh, M Frenkel, L Poretsky - Metabolism open, 2021 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is a multifactorial metabolic disorder that was first
described in 1980. It has been prevalent and on the rise for many years and is associated …
described in 1980. It has been prevalent and on the rise for many years and is associated …